Grifols, ES0171996087

Grifols stock trades at EUR 10.03 with EUR 6.8 billion market value

Published on 10/12/2026 at 14:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Grifols stock is at EUR 10.03 on October 12, 2026, with EUR 6.8 billion market value. Next earnings are listed for November 10, 2026.

Key points in brief

Grifols stock was trading at EUR 10.03 at Lang & Schwarz on October 12, 2026.
The stock's market capitalization was EUR 6.8 billion, with a 52-week range of EUR 8.43 to EUR 12.21.
The next earnings date is listed as November 10, 2026.

Pop-Art-Comic mit Labortechnikern, Plasmabeuteln und Halbtonpunkten — Pop-Art-Comic-Szene mit Labortechnikern und Plasmabeuteln visualisiert farbenfroh die Branche von Grifols S.A. ES0171996087, Illustration mit AI erstellt.

At Lang & Schwarz, Grifols (ISIN ES0171996087) was trading at EUR 10.03 on October 12, 2026 at 2:00 p.m. CEST. The market value attached to the stock was EUR 6.8 billion, giving the current quote a clear scale for investors.

Quote sits below yearly high

The latest quote was EUR 2.18 below the 52-week high of EUR 12.21 and EUR 1.60 above the 52-week low of EUR 8.43. That places the price 17.85 percent below the high, while the range itself shows that the stock remains closer to its upper boundary than to its annual low.

Global Banking and Finance Review identifies Grifols as GRF.MC on BME under ISIN ES0171996087. The listing is in the healthcare sector, with the business centered on plasma-derived medicines and related diagnostic products.

Valuation and income profile

The quoted price carried a trailing P/E ratio of 14.96 and a dividend yield of 0.01 percent on October 12, 2026. Average trading volume was 1,492,102 shares, compared with current volume of 336,383 shares, so the session had recorded 22.55 percent of the average volume at the finance-data timestamp.

Comparison with peers

Grifols: , P/E 14.96, market capitalization EUR 6.8 billion
CSL (ASX, AUD): plus 0.53 percent, P/E minus 24.31, market capitalization AUD 88.5 billion
IBEX 35: plus 0.87 percent, ,

Next reporting date

TradingView lists November 10, 2026 as the next earnings date for Grifols preferred Class B stock. The date gives investors a defined calendar point for the next fundamental update, while the current market figures show the valuation and liquidity backdrop before that event.

Market price and investor context

For the market report, the key reference is the EUR 10.03 Lang & Schwarz quote on October 12, 2026, alongside the EUR 6.8 billion market capitalization and the EUR 8.43 to EUR 12.21 yearly range. These figures frame the stock without turning the market report into a trading recommendation.

The further course of trading is shown by the continuously updated real-time quote of Grifols stock.